|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005740,
umls-concept:C0008838,
umls-concept:C0015133,
umls-concept:C0027651,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0205070,
umls-concept:C0405581,
umls-concept:C0441766,
umls-concept:C0442711,
umls-concept:C0443252,
umls-concept:C0679729,
umls-concept:C0684224,
umls-concept:C1511572,
umls-concept:C1518411,
umls-concept:C1518578,
umls-concept:C1522673
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-3-2
|
|
pubmed:abstractText |
Stage I testicular nonseminomatous germ-cell tumors (NSGCT) are highly curable. Following orchidectomy surveillance, adjuvant chemotherapy and retroperitoneal lymph node dissection can be applied. Certain factors are used to select patients in high-risk for relapse. We report the outcome and safety of a risk-adapted strategy by the Hellenic Cooperative Oncology Group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1873-2496
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
189-93
|
|
pubmed:meshHeading |
pubmed-meshheading:19362863-Adolescent,
pubmed-meshheading:19362863-Adult,
pubmed-meshheading:19362863-Alopecia,
pubmed-meshheading:19362863-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19362863-Bleomycin,
pubmed-meshheading:19362863-Chemotherapy, Adjuvant,
pubmed-meshheading:19362863-Cisplatin,
pubmed-meshheading:19362863-Drug Administration Schedule,
pubmed-meshheading:19362863-Etoposide,
pubmed-meshheading:19362863-Follow-Up Studies,
pubmed-meshheading:19362863-Humans,
pubmed-meshheading:19362863-Male,
pubmed-meshheading:19362863-Middle Aged,
pubmed-meshheading:19362863-Nausea,
pubmed-meshheading:19362863-Neoplasm Staging,
pubmed-meshheading:19362863-Neoplasms, Germ Cell and Embryonal,
pubmed-meshheading:19362863-Neutropenia,
pubmed-meshheading:19362863-Retrospective Studies,
pubmed-meshheading:19362863-Testicular Neoplasms,
pubmed-meshheading:19362863-Time Factors,
pubmed-meshheading:19362863-Treatment Outcome,
pubmed-meshheading:19362863-Vomiting,
pubmed-meshheading:19362863-Young Adult
|
|
pubmed:articleTitle |
Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): a risk adapted protocol of the Hellenic Cooperative Oncology Group.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, Medical School, University of Athens, Athens, Greece. abamias@med.uoa.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
